Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects

Heme oxygenase (HO) plays a critical role in the regulation of cellular oxidative stress. The effects of the reactive oxygen species scavenger ebselen and the HO inducers cobalt protoporphyrin and stannous chloride (SnCl2) on HO protein levels and activity, indices of oxidative stress, and the progression of diabetes were examined in the Zucker rat model of type 2 diabetes. The onset of diabetes coincided with an increase in HO-1 protein levels and a paradoxical decrease in HO activity, which was restored by administration of ebselen. Up-regulation of HO-1 expressed in the early development of diabetes produced a decrease in oxidative/nitrosative stress as manifested by decreased levels of 3-nitrotyrosine, superoxide, and cellular heme content. This was accompanied by a decrease in endothelial cell sloughing and reduced blood pressure. Increased HO activity was also associated with a significant increase in the antiapoptotic signaling molecules Bcl-xl and phosphorylation of p38-mitogen-activated protein kinase but no significant increases in Bcl-2 or BAD proteins. In conclusion, 3-nitrotyrosine, cellular heme, and superoxide, promoters of vascular damage, are reduced by HO-1 induction, thereby preserving vascular integrity and protecting cardiac function involving an increase in antiapoptotic proteins.

[1]  N. Abraham,et al.  Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental Diabetes* , 2006, Journal of Biological Chemistry.

[2]  B. Demple,et al.  Carbon monoxide mediates protection against nitric oxide toxicity in HeLa cells. , 2005, Free radical biology & medicine.

[3]  G. Mealing,et al.  An alternative Ca2+‐dependent mechanism of neuroprotection by the metalloporphyrin class of superoxide dismutase mimetics , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  G. Li Volti,et al.  Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth. , 2005, Cellular and molecular biology.

[5]  A. Holmgren,et al.  Ebselen: A thioredoxin reductase-dependent catalyst for α-tocopherol quinone reduction , 2005 .

[6]  L. Rodella,et al.  Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. , 2005, American journal of physiology. Heart and circulatory physiology.

[7]  B. McManus,et al.  Compromised arterial function in human type 2 diabetic patients. , 2005, Diabetes.

[8]  N. Abraham,et al.  Heme oxygenase and the cardiovascular-renal system. , 2005, Free radical biology & medicine.

[9]  N. Abraham,et al.  D-4F Induces Heme Oxygenase-1 and Extracellular Superoxide Dismutase, Decreases Endothelial Cell Sloughing, and Improves Vascular Reactivity in Rat Model of Diabetes , 2005, Circulation.

[10]  Xin-Yuan Fu,et al.  Carbon Monoxide Differentially Modulates STAT1 and STAT3 and Inhibits Apoptosis via a Phosphatidylinositol 3-Kinase/Akt and p38 Kinase-dependent STAT3 Pathway during Anoxia-Reoxygenation Injury* , 2005, Journal of Biological Chemistry.

[11]  M. Layne,et al.  Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. , 2005, Diabetes.

[12]  N. Abraham,et al.  Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. , 2005, Diabetologia.

[13]  A. Holmgren,et al.  Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction. , 2005, Toxicology and applied pharmacology.

[14]  N. Abraham,et al.  Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c , 2005, Diabetologia.

[15]  L. Rodella,et al.  Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. , 2004, American journal of physiology. Heart and circulatory physiology.

[16]  N. Abraham,et al.  Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. , 2004, Biochemical and biophysical research communications.

[17]  S. Ryter,et al.  Carbon monoxide in biology and medicine , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  R. Fässler,et al.  Modulation of Ca2+ Sensitivity by Cyclic Nucleotides in Smooth Muscle from Protein Kinase G-deficient Mice* , 2004, Journal of Biological Chemistry.

[19]  G. Farrugia,et al.  Heme: a determinant of life and death in renal tubular epithelial cells. , 2004, American journal of physiology. Renal physiology.

[20]  Ernesto L. Schiffrin,et al.  Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  N. Abraham,et al.  Human heme oxygenase: Cell cycle‐dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells , 2003, Journal of cellular biochemistry.

[22]  Z. Darżynkiewicz,et al.  Heme Oxygenase-1 Attenuates Glucose-Mediated Cell Growth Arrest and Apoptosis in Human Microvessel Endothelial Cells , 2003, Circulation research.

[23]  M. Febbraio,et al.  Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. , 2003, Diabetes.

[24]  R. Flavell,et al.  Carbon Monoxide Modulates Fas/Fas Ligand, Caspases, and Bcl-2 Family Proteins via the p38α Mitogen-activated Protein Kinase Pathway during Ischemia-Reperfusion Lung Injury* , 2003, Journal of Biological Chemistry.

[25]  James D. Johnson,et al.  Increased islet apoptosis in Pdx1+/- mice. , 2003, The Journal of clinical investigation.

[26]  D. Kereiakes,et al.  Endothelial dysfunction. , 2003, Circulation.

[27]  H. Volk,et al.  Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. , 2002, Human gene therapy.

[28]  Z. Mareček,et al.  Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. , 2002, Atherosclerosis.

[29]  R. Cohen,et al.  High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. , 2002, Diabetes.

[30]  K. Nath,et al.  Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. , 2000, Kidney international.

[31]  G. Etgen,et al.  Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. , 2000, Metabolism: clinical and experimental.

[32]  K. Matsumoto,et al.  Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. , 1999, Circulation research.

[33]  S. Milstien,et al.  Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. , 1999, Biochemical and biophysical research communications.

[34]  R. Robertson,et al.  Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Platt,et al.  Heme oxygenase: Protective gene or Trojan horse , 1998, Nature Medicine.

[36]  A. Lusis,et al.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.

[37]  N. Abraham,et al.  Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. , 1997, Biochemical pharmacology.

[38]  S. Shibahara,et al.  Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. , 1997, Current eye research.

[39]  J. Alam,et al.  Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. , 1995, Kidney international.

[40]  G. Vercellotti,et al.  Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. , 1992, The Journal of clinical investigation.

[41]  N. Abraham,et al.  Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. , 1989, Science.

[42]  L. Zucker.  HEREDITARY OBESITY IN THE RAT ASSOCIATED WITH HYPERLIPEMIA * , 1965, Annals of the New York Academy of Sciences.